Dendritic Cells

Dendritic cells (DCs) have long been recognized as the most potent antigen-producing cells with the capacity to initiate naive T cell response in vitro and in vivo. During their differentiation and maturation pathways, dendritic cells can efficiently capture, process and present antigens for T cell activation making DCs an attractive choice for cancer vaccines.

Tools, technologies, antibodies and detection methods from Beckman Coulter are helping researchers take a more holistic approach to understanding the immune response and how it plays out in pathogenic disease.

Dendritic Cells Resources

  • Filter by:

Additional Research Topics and Information

Contact Us


















Please keep me informed about Beckman Coulter webinars, products, goods, and services, including products, goods, or services from our related companies.



By submitting this form I confirm that I have reviewed and agree with the Privacy Policy and Terms of Use. I also understand my privacy choices as they pertain to my personal data as provided in the Privacy Policy under “Your Privacy Choices”.